文献速递腹部技术与安全CT

一项采用动态对比增强CT协议检测结直肠癌肝转移的前瞻性临床研究

A prospective clinical study using a dynamic contrast-enhanced CT-protocol for detection of colorectal liver metastases.
PubMed 文献 · Eur J Radiol · 2018-08-30

前瞻性纳入135例未治疗结直肠癌患者,行动态对比增强CT(含灌注图)与常规单期门静脉期胸腹盆CT,42例存在肝转移。动态CT在肝转移检出和病灶清晰度上均优于门静脉期CT(P=0.016和P<0.001),对小于15 mm病灶检出更优,辐射剂量增量相对较低。

要点

  • 动态对比增强CT(含灌注图)对结直肠癌肝转移的检出和病灶清晰度均优于常规单期门静脉期CT。
  • 动态对比增强CT对小于15 mm的肝转移灶检出优势更明显。
  • 动态对比增强CT的辐射剂量增量相对较低。

核心结论

  • 动态对比增强CT较单期门静脉期CT提高结直肠癌肝转移检出率,尤其对小于15 mm病灶,并改善病灶清晰度,可能正向影响阅片者信心和临床工作流程。

研究设计与样本

  • 前瞻性临床研究,纳入135例未治疗结直肠癌患者,行动态对比增强CT后行常规单期门静脉期胸腹盆CT,42例存在肝转移,比较两种方法检出病灶数目和病灶清晰度。

关键影像表现/征象

  • 动态对比增强CT在检出和病灶清晰度上均优于门静脉期CT,检出比较Wilcoxon符号秩检验P=0.016,清晰度比较P<0.001。
  • 动态对比增强CT对小于15 mm的结直肠癌肝转移灶检出优于单期门静脉期CT。

临床应用与阅片要点

  • 作者结论认为动态对比增强CT可提高结直肠癌肝转移检出,尤其对小于15 mm病灶,并改善病灶清晰度,可能正向影响阅片者信心和临床工作流程。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate a dynamic contrast-enhanced CT-protocol and compare this method with standard of care monophasic portovenous CT for detection of colorectal liver metastases.

MATERIALS AND METHODS: A dynamic contrast-enhanced CT protocol was developed to detect liver metastasis in patients suffering from colorectal cancer, in clinical practice. The study was approved by the Hospital Ethics Committee. Written informed consent was obtained from all patients. 135 patients were included in this prospective study. All patients were naive to treatment. A dynamic contrast-enhanced CT was performed, followed by routine monophasic portovenous CT of thorax-abdomen-pelvis. 42 of these patients presented with liver metastasis. The number and lesion conspicuity of detected liver metastasis on dynamic contrast-enhanced CT using perfusion maps, was compared to monophasic CT.

RESULTS: 135 patients were included, of which 42 presented with metastases to the liver. Dynamic contrast-enhanced CT outperformed portovenous CT for detection as well as conspicuity of colorectal liver metastasis, at a relatively low dose increment. Wilcoxon Signed Rank test had a p-value of 0.016 and <0.001 respectively for detection and conspicuity of colorectal liver metastasis.

CONCLUSION: Dynamic contrast-enhanced CT increases the detection of colorectal liver metastasis, especially for lesions smaller than 15 mm, when compared to monophasic portovenous CT. Dynamic contrast-enhanced CT also has the added advantage of improved lesion conspicuity, which can positively influence reader confidence and clinical workflow.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Van Camp L, Deak P, Haspeslagh M, et al. A prospective clinical study using a dynamic contrast-enhanced CT-protocol for detection of colorectal liver metastases. Eur J Radiol. 2018. PMID: 30292259. doi:10.1016/j.ejrad.2018.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。